Recurrent Abortion
7
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Histopathological Evaluation of Product of Conception in Sporadic and Recurrent Abortions
Sildenafil Citrate and Recurrent Abortion
Laparoscopic Transabdominal Cerclage: New Approach
Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion
the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION
Optimum Misoprostol Dose Prior to Office Hysteroscopy
Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome